VEGFR1 (vascular endothelial growth factor receptor 1) and VGFR2 (vascular endothelial growth factor receptor 2) are both client proteins of Hsp90 [56], suggesting that Hsp90 inhibitors can inhibit VEGFR production by tumor cells to block cell proliferation. Here, FLT1 is linked to neoplasm.